MARKET

RNVEF

RNVEF

Renerve Ltd
EXMKT
--
NaN%
Closed
OPEN
--
PREV CLOSE
--
HIGH
--
LOW
--
VOLUME
--
TURNOVER
--
52 WEEK HIGH
--
52 WEEK LOW
--
MARKET CAP
--
P/E (TTM)
--
1D
5D
1M
3M
1Y
5Y
1D
No Data
About RNVEF
ReNerve Limited is an Australia-based biotechnology company engaged in advanced nerve repair and regeneration solutions. The Company is focused on commercializing medical devices and tissue engineering products that address significant unmet needs in peripheral nerve damage patients. It is also developing tissue-based products for peripheral nerve repair and replacement and other related soft tissue surgical procedures. It is focused on developing products that accelerate tissue regeneration while preventing scarring and negative inflammatory responses. Its products include NervAlign Nerve Cuff, NervAlign Nerve Graft and NervAlign Bionic Nerve. NervAlign Nerve Cuff is a soft, tissue compatible protective wrap used to protect repaired injured nerves. It consists of a pliable scaffolding material that can be wrapped around the nerve, protecting surgical repairs and conforming to the nerve’s final shape, allowing regeneration to occur.

Webull offers ReNerve Ltd stock information, including EXMKT: RNVEF real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, RNVEF stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading RNVEF stock methods without spending real money on the virtual paper trading platform.